[1]
“EVALUATION OF THE EFFECT OF METFORMIN ON SERUM INFLAMMATORY BIOMARKERS (CRP, IL-6) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, RMSR, vol. 3, no. 5, pp. 982–987, May 2025, Accessed: Aug. 07, 2025. [Online]. Available: https://medscireview.net/index.php/Journal/article/view/1235